• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Patent holdings for IPC class A61K 47/60

Total number of patents in this class: 3887

10-year publication summary

119
225
351
433
391
434
419
404
384
295
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Nektar Therapeutics
437
89
Hanmi Pharm. Co., Ltd.
575
71
The Regents of the University of California
20230
61
Bristol-myers Squibb Company
4848
47
Ascendis Pharma A/S
184
44
The Johns Hopkins University
5739
42
Massachusetts Institute of Technology
10129
40
Ascendis Pharma Growth Disorders A/S
57
39
Synthorx, Inc.
82
35
Board of Regents, The University of Texas System
5917
34
Ascendis Pharma Bone Diseases A/S
48
27
Amgen Inc.
4158
26
Quiapeg Pharmaceuticals AB
45
26
Janssen Pharmaceutica N.V.
3349
24
NOK Corporation
2239
23
The Board of Trustees of the Leland Stanford Junior University
6509
22
Northwestern University
3442
22
SeaGen Inc
594
21
Ambrx, Inc.
181
20
Yale University
2433
20
Other owners 3154